Contact us :
Whatsapp:+86 156 3213 8192
Wickr pro:1174573833@qq.com
Wickr:kmbktaylor
Email:aric258@163.com
new bmk/cas 5413-05-8
bmk cas 16648-44-5
Pmk cas 13605-48-6
new pmk cas 28578-16-7
MK2866 841205-47-8
S4 401900-40-1
S23 1010396-29-8
LGD-4033 1165910-22-4
MK677 159752-10-0
SR9009 1379686-30-2
SR9011 1379686-29-9
ACP-105 899821-23-9
YK-11 1370003-76-1
GW-0742 317318-84-6
RAD-140 118237-47-0
GW-501516 317318-70-0
N,N-dimethyl-2-phenylethylamine hydrochloride (USAF EL-79) 10275-21-5
cas 1451-82-7
cas 49851-31-2
BDO cas 110-63-4
Tetracaine hcl cas 136-47-0
Procaine cas 59-46-1
Lidocaine cas 137-58-6
Benzocaine cas 94-09-7
| Product Name: | AZD 3759 |
| Synonyms: | AZD 3759;AZD3759;AZD-3759;(2R)-2,4-Dimethyl-1-piperazinecarboxylic acid 4-[(3-chloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl ester;HY-18750;azd3579;1-Piperazinecarboxylic acid, 2,4-dimethyl-, 4-[(3-chloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl ester, (2R)-;1-PIPERAZINECARBOXYLIC ACID, 2,4-DIMETHYL-, 4-[(3-CHLORO-2-FLUOROPHENYL)AMINO]-7-METHOXY-6-QUINAZOLINYL ESTER |
| CAS: | 1626387-80-1 |
| MF: | C22H23ClFN5O3 |
| MW: | 459.9 |
| EINECS: | 1592732-453-0 |
| Product Categories: | API |
| Mol File: | 1626387-80-1.mol |
 |
|
| AZD 3759 Chemical Properties |
| Boiling point | 571.4±50.0 °C(Predicted) |
| density | 1.358±0.06 g/cm3(Predicted) |
| pka | 6.71±0.40(Predicted) |
|
| AZD 3759 Usage And Synthesis |
| Selective EGFR inhibitor | AZD3759 is a selective EGFR inhibitor that can fully penetrate the blood-brain barrier (BBB), with equal free concentrations in the blood, cerebrospinal fluid, and brain tissue. Treatment with AZD3759 causes tumor regression in subcutaneous xenograft, leptomeningeal metastasis (LM), and brain metastasis (BM) lung cancer models and prevents the development of BM in nude mice. |
| Description | AZD3759 is an EGFP inhibitor (Epidermal growth factor receptor tyrosine kinase inhibitor) with blood brain barrier (BBB) penetration. It has the potential for the treatment of non-small cell lung cancer (NSCLC), with brain metastases (BM) and leptomengingeal metastases (LM) since this type of cancer often contain a lot of activating mutations of the epidermal growth factor receptor (EGFR). It has excellent capability of penetrating the blood brain barrier to reach the central nervous system |
NMN cas 1094-61-7
NR cas 1341-23-7
Boric acid cas 11113-50-1
N-Isopropylbenzylamine cas 102-97-6
Tetramisole hcl cas 5086-74-8
Levamisole cas 14769-73-4
Phenacetin cas 62-44-2
2-iodo-1-p-tolyl-propan-1-one cas 236117-38-7
Paracetamol cas 103-90-2
Pregabalin cas 148553-50-8
Xylazine cas 7361-61-7
(2-Bromoethyl)benzene cas 103-63-9
4'-Methylpropiophenone
cas 5337-93-9
Valerophenone cas 100
China
